Synopex Balance Sheet Health
Financial Health criteria checks 6/6
Synopex has a total shareholder equity of ₩134.1B and total debt of ₩28.7B, which brings its debt-to-equity ratio to 21.4%. Its total assets and total liabilities are ₩201.3B and ₩67.2B respectively. Synopex's EBIT is ₩24.2B making its interest coverage ratio 11.2. It has cash and short-term investments of ₩27.4B.
Key information
21.4%
Debt to equity ratio
₩28.67b
Debt
Interest coverage ratio | 11.2x |
Cash | ₩27.40b |
Equity | ₩134.13b |
Total liabilities | ₩67.19b |
Total assets | ₩201.31b |
Recent financial health updates
Recent updates
Why Synopex Inc. (KOSDAQ:025320) Could Be Worth Watching
Apr 18Synopex's (KOSDAQ:025320) Performance Is Even Better Than Its Earnings Suggest
Mar 26Market Participants Recognise Synopex Inc.'s (KOSDAQ:025320) Revenues Pushing Shares 55% Higher
Mar 11Here's Why Synopex (KOSDAQ:025320) Can Afford Some Debt
Feb 16Synopex (KOSDAQ:025320) Shareholders Have Enjoyed An Impressive 227% Share Price Gain
Dec 25Financial Position Analysis
Short Term Liabilities: A025320's short term assets (₩83.6B) exceed its short term liabilities (₩54.3B).
Long Term Liabilities: A025320's short term assets (₩83.6B) exceed its long term liabilities (₩12.9B).
Debt to Equity History and Analysis
Debt Level: A025320's net debt to equity ratio (0.9%) is considered satisfactory.
Reducing Debt: A025320's debt to equity ratio has reduced from 83.1% to 21.4% over the past 5 years.
Debt Coverage: A025320's debt is well covered by operating cash flow (167.7%).
Interest Coverage: A025320's interest payments on its debt are well covered by EBIT (11.2x coverage).